Axsome Therapeutics, Inc.
AXSM · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 10, 2026 | — | 221.89M | — | -0.99 | — |
| 2026 Q1 | May 4, 2026 | 189.40M | 190.91M | -1.26 | -0.85 | +8.31% |
| 2025 Q4 | February 23, 2026 | 194.70M | 193.36M | -0.71 | -0.70 | -4.88% |
| 2025 Q3 | November 3, 2025 | 170.99M | 191.33M | -0.94 | -0.82 | +0.56% |
| 2025 Q2 | August 4, 2025 | 150.04M | 140.02M | -0.92 | -1.00 | +3.42% |
| 2025 Q1 | May 5, 2025 | 121.46M | 140.44M | -0.80 | -1.26 | +3.81% |
| 2024 Q4 | February 18, 2025 | 118.77M | 119.51M | -0.96 | -1.00 | -2.33% |
| 2024 Q3 | November 12, 2024 | 104.76M | 98.37M | -1.34 | -1.38 | +9.35% |
| 2024 Q2 | August 5, 2024 | 87.17M | 86.92M | -1.24 | -1.30 | -1.43% |
| 2024 Q1 | May 6, 2024 | 75.00M | 86.66M | -1.09 | -1.20 | +1.52% |
| 2023 Q4 | February 20, 2024 | 71.53M | 67.56M | -0.73 | -1.21 | -12.57% |
| 2023 Q3 | November 6, 2023 | 57.79M | 55.75M | -1.32 | -1.24 | -4.18% |
| 2023 Q2 | August 7, 2023 | 46.70M | 40.93M | -1.00 | -1.24 | -3.49% |
| 2023 Q1 | May 8, 2023 | 94.58M | 26.62M | -0.22 | -1.13 | +5.41% |
| 2022 Q4 | February 27, 2023 | 24.37M | 21.75M | -1.28 | -1.18 | +4.96% |
| 2022 Q3 | November 7, 2022 | 16.85M | 16.64M | -1.03 | -1.10 | -0.47% |